APA (7th ed.) Citation

PCM, A., BA, C., JR, H., IQ, M., KJ, L., 3rd, B. W., . . . AA, J. (2025). Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy. Annals of surgical oncology, 32(9), 6550. https://doi.org/10.1245/s10434-025-17439-x

Chicago Style (17th ed.) Citation

PCM, Andel, et al. "Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy." Annals of Surgical Oncology 32, no. 9 (2025): 6550. https://doi.org/10.1245/s10434-025-17439-x.

MLA (9th ed.) Citation

PCM, Andel, et al. "Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant Therapy." Annals of Surgical Oncology, vol. 32, no. 9, 2025, p. 6550, https://doi.org/10.1245/s10434-025-17439-x.